Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia

Biological Psychiatry

Volumn 55, Issue 10, 2004, Pages 981-988

  Stopkova, Pavla ^a   Saito, Takuya ^b   Papolos, Demitri F ^b   Vevera, Jan ^a   Paclt, Ivo ^a   Zukov, Ilja ^a   Bersson, Yonina B ^b   Margolis, Benjamin A ^b   Strous, Rael D ^c   Lachman, Herbert M ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bipolar disorder; Brn; inositol phosphates; lithium; oct 1; phosphatidylinositol; phosphoinositide; POU; schizophrenia

Indexed keywords

BRAIN PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COHORT ANALYSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MOLECULAR RECOGNITION; MOOD DISORDER; MULTIGENE FAMILY; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SCHIZOPHRENIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALLELES; ANIMALS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONSENSUS SEQUENCE; DNA MUTATIONAL ANALYSIS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENOTYPE; HEART; HUMANS; KIDNEY; LINKAGE DISEQUILIBRIUM; LIVER; MICE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 2342507816     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.01.014     Document Type: Article

References (73)

1. Badenhop R.F., Moses M.J., Scimone A., Mitchell P.B., Ewen-White K.R., Donald J.A., et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 was well as chromosomes 9, 13, and 19. Mol Psychiatry. 7:2002;851-859
2. Barrett T.B., Hauger R.L., Kennedy J.L., Sadounick A.D., Remnick R.A., Keck P.E., et al. Evidence for a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry. 8:2003;546-557
3. Berrettini W.H. Are schizophrenia and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry. 48:2000;531-538
4. Berrettini W.H., Ferraro T.N., Goldin L.R., Weeks D.E., Detera-Wadleigh S., Nurnberger J.I. Jr, Gershon E.S. Chromosome 18 DNA markers and manic-depressive illness Evidence for a susceptibility gene. Proc Natl Acad Sci U S A. 91:1994;5918-5921
5. Berridge M.J., Irvine R.F. Inositol phosphates and cell signaling. Nature. 341:1989;197-205
6. Brzustowicz L.M., Hodgkinson K., Chow E.W., Honer W.G., Bassett A.S. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 288:2000;678-682
7. Casebolt T.L., Jope R.S. Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry. 29:1991;233-243
8. Castellino A.M., Chao M.V. Differential association of phosphatidylinositol-5-phosphate 4-kinase with the EGF/ErbB family of receptors. Cell Signal. 11:1999;171-177
9. Cremona O., De Camilli P. Phosphoinositides in membrane traffic at the synapse. J Cell Sci. 114:2001;1041-1052
10. Daw M.I., Bortolotto Z.A., Saulle E., Zaman S., Collingridge G.L., Isaac J.T.R. Phosphatidylinositol 3 kinase regulates synaptic specificity of hippocampal long-term depression. Nat Neurosci. 5:2002;835-836
11. Detera-Wadleigh S.D., Badner J.A., Berrettini W.H., Yoshikawa T., Goldin L.R., Turner G., et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci U S A. 96:1999;5604-5609
12. Detera-Wadleigh S.D., Badner J.A., Yoshikawa T., Sanders A.R., Goldin L.R., Turner G., et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees Chromosomes 4, 7, 9, 18 19 20, and 21q. Am J Med Genet. 74:1997;254-262
13. Dixon J.F., Hokin L.E. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1, 4, 5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Proc Natl Acad Sci U S A. 94:1997;4757-4760
14. Eberhard D.A., Cooper C.L., Low M.G., Holz R.W. Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. Biochem J. 268:1990;15-25
15. Ekelund J., Hovatta I., Parker A., Paunio T., Varilo T., Martin R., et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet. 10:2001;1611-1617
16. Elsholtz H.P., Albert V.R., Treacy M.N., Rosenfeld M.G. A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. Genes Dev. 4:1990;43-51
17. Endicott J., Spitzer R.L. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 35:1978;837-844
18. Escamilla M.A., McInnes L.A., Service S.K., Spesny M., Reus V.I., Molina J., et al. Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder A follow-up study on chromosome 18. Am J Med Genet. 105:2001;207-213
19. Ewald H., Flint T.J., Jorgensen T.H., Wang A.G., Jensen P., Vang M., et al. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am J Med Genet. 114:2002;196-204
20. Ewald H., Mors O., Koed K., Eiberg H., Kruse T.A. Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families. Psychiatr Genet. 7:1997;1-12
21. Faraone S.V., Matise T., Svrakic D., Pepple J., Malaspina D., Suarez B., et al. Genome scan of European-American schizophrenia pedigrees Results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet. 81:1998;290-295
22. Faraone S.V., Meyer J., Matise T., Svrakic D., Pepple J., Malaspina D., et al. Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. Am J Med Genet. 88:1999;607-608
23. Foroud T., Castelluccio P.F., Koller D.L., Edenberg H.J., Miller M., Bowman E., et al. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet. 96:2000;18-23
24. Ginns E.I., St Jean P., Philibert R.A., Galdzicka M., Damschroder-Williams P., Thiel B., et al. A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proc Natl Acad Sci U S A. 95:1998;15531-15536
25. Hallcher L., Sherman W.R. The effects of lithium and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 261:1980;8100-8130
26. Her W., Cleary M.A. The POU domain: Versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1995;1679-1693
27. Hilton J.M., Plomann M., Ritter B., Mondregger J., Freeman H.N., Falck J.R., et al. Phosphorylation of a synaptic vesicle-associated protein by an inositol hexakisphosphate-regulated protein kinase. J Biol Chem. 276:2001;16341-16347
28. Holz R.W., Hlubek M.D., Sorensen S.D., Fisher S.K., Balla T., Ozaki S., et al. A pleckstrin homology domain specific for phosphatidylinositol 4, 5-bisphosphate (PtdIns-4, 5-P2) and fused to green fluorescent protein identifies plasma membrane PtdIns-4, 5-P2) as being important in exocytosis. J Biol Chem. 275:2000;17878-17885
29. Hope B.T., Kelz M.B., Duman R.S., Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci. 14:1994;4318-4328
30. Ilia M., Beasley C., Meijer D., Kerwin R., Cotter D., Everall I., Price J. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. Am J Psychiatry. 159:2002;1174-1182
31. Jope R.S., Bijur G.N. Mood stabilizers, glycogen synthase kinase-3 beta and cell survival. Mol Psychiatry. 7:(suppl 1):2002;S35-45
32. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A. 93:1996;8455-8459
33. Lachman H.M., Kelsoe J.R., Remick R.A., Sadovnick A.D., Rapaport M.H., Lin M., et al. Linkage studies support a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. Am J Med Genet. 74:1997;121-128
34. Latchman D.S. POU family transcription factors in the nervous system. J Cell Physiol. 179:1999;126-133
35. Lenox R.H., Wang L. Molecular basis of lithium action Integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry. 8:2003;135-144
36. Levinson D.F., Holmans P., Straub R.E., Owen M.J., Wildenauer D.B., Gejman P.V., et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q Schizophrenia linkage collaborative group III. Am J Hum Genet. 67:2000;652-663
37. Levinson D.F., Mahtani M.M., Nancarrow D.J., Brown D.M., Kruglyak L., Kirby A., et al. Genome scan of schizophrenia. Am J Psychiatry. 155:1998;741-750
38. Li B.S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., et al. Cyclin-dependent kinase-5 involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediated neuronal survival. J Biol Chem. 278:2003;35702-35709
39. Lin C.H., Yeh S.H., Lin C.H., Lu K.T., Leu T.H., Chang W.C., Gean P.W. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 31:2001;841-851
40. Malik K.F., Jaffe H., Brady J., Young W.S. 3d. The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. Brain Res Mol Brain Res. 45:1997;99-107
41. Manji H.K., Moore G.J., Chen G. Bipolar disorder Leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry. 41:(suppl):2001;S107-109
42. Maziade M., Roy M.A., Rouillard E., Bissonnette L., Fournier J.P., Roy A., et al. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder A linkage study in 13 target chromosomes. Mol Psychiatry. 6:2001;684-693
43. McPherson P.S., Garcia E.P., Slepnev V.I., David C., Zhang X., Grabs D., et al. A presynaptic inositol-5-phosphatase. Nature. 379:1996;353-357
44. Merlot S., Firtel R.A. Leading the way Directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci. 116:2003;3471-3478
45. Mochida S., Fukuda M., Niinobe M., Kobayashi H., Mikoshiba K. Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high polyphosphate binding at mammalian cholinergic synapses. Neuroscience. 77:1997;937-943
46. Mowry B.J., Ewen K.R., Nancarrow D.J., Lennon D.P., Nertney D.A., Jones H.L., et al. Second stage of a genome scan of schizophrenia Study of five positive regions in an expanded sample. Am J Med Genet. 96:2000;864-869
47. Naga Prasad S.V., Barak L., Rapacciuolo A., Caron M.G., Rockman H.A. Agonist dependent recruitment of phosphoinositide 3-kinase to the membrane by beta adrenergic receptor kinase. A role in receptor sequestration. J Biol Chem. 276:2001;18953-18959
48. Naga Prasad S.V., Laporte S.A., Chamberlain D., Caron M.G., Barak L., Rockman H.A. Phosphoinositide 3-kinase regulates beta 2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta arrestin complex. J Cell Biol. 158:2002;563-575
49. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipid and activation of protein kinase C. Science. 258:1992;607-614
50. Nurnberger J.I., Foroud T. Chromosome 6 workshop report. Am J Med Genet. 88:1999;233-238
51. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 86:1989;2766-2770
52. Perez-Juste G., Garcia-Silva S., Aranda A. An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J Biol Chem. 275:2000;1307-1314
53. Phillips K., Luisi B. The virtuosity of versatility POU proteins that flex and fit. J Mol Biol. 302:2000;1023-1039
54. Rice J.P., Goate A., Williams J.T., Bierut L., Dorr D., Wu W., et al. Am J Med Genet. 74:1997;247-253
55. Saito T., Guan F., Papolos D.F., Lau S., Klein M., Fann C.S., Lachman H.M. Mutation analysis of SYNJ1 A possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry. 6:2001;387-395
56. Schwab S.G., Hallmayer J., Albus M., Lerer B., Hnases C., Kanyas K., et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet. 81:1998;302-307
57. Schwab S.G., Sklar P., Hallmayer J., Albus M., Singh H., Sen R., et al. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature. 319:1986;154-158
58. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet. 81:1998;364-376
59. Singh H., Sen R., Baltimore D., Sharp P.A. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature. 319:1986;154-158
60. Spitzer R.L., Endicott J., Robins E. Research diagnostic criteria Rationale and reliability. Arch Gen Psychiatry. 35:1978;773-782
61. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., et al. Association of neuregulin 1 with schizophrenia confirmed in Scottish population. Am J Hum Genet. 72:2003;83-87
62. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71:2002;877-892
63. Stopkova P, Saito T, Fann CSJ, Papolos DF, Vevera J, Paclt I, et al (2003): Polymorphism screening of PIP5K2A: A candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet(online) 14 Mar 2003, DOI 10 1002/ajmg:b.:20012
64. Straub R.E., Lehner T., Luo Y., Loth J.E., Shao W., Sharpe L. A possible vulnerability locus for BP affective disorder on chromosome 21. Nat Genet. 8:1994;291-296
65. Straub R.E., MacLean C.J., Myakishev M.V., Harris-Kerr C., O'Neil F.A., Walsh D., Kendler K.S. A schizophrenia locus may be located in region 10p15.1. Am J Med Genet. 81:1998;296-301
66. Sun G.Y., Navidi M., Yoa F.G., Lin T.N., Orth O.E., Stubbs E.B., MacQuarrie R.A. Lithium effects on inositol phospholipids and inositol phosphates Evaluation of an in vivo model for assessing polyphosphoinositide turnover in brain. J Neurochem. 58:1992;290-297
67. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:1997;673-676
68. Tsuang D.W., Skol A.D., Faraone S.V., Bingham S., Young K.A., Prabhudesai S., et al. Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs cooperative study sample. Am J Med Genet. 105:2001;662-668
69. Wenk M.R., Pellegrini L., Klenchin V.A., Di Paolo G., Chang S., et al. PIP kinase Igamma is the majot PI(, 5)P(2) synthesizing enzyme at the synapse. Neuron. 32:2001;79-88
70. Wymann M.P., Pirola L. Structure and function of phosphoinositide 3-kinases. Biochem Biophys Acta. 1436:1998;127-150
71. Yang F., He X.-P., Feng L., Mizuno K., Liu X.-W., Russell J., et al. PI-3 kinase and IP3 are both necessary and sufficient to mediate NT-3-induced synaptic potentiation. Neuron. 4:2001;19-28
72. Yoshikawa T., Kikuchi M., Saito K., Watanabe A., Yamada K., Shibuya H., et al. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples. Mol Psychiatry. 6:2001;202-210
73. Zhao F.Q., Adachi K., Oka T. Involvement of Oct-1 in transcriptional regulation beta-casein gene expression in mouse mammary gland. Biochim Biophys Acta. 1577:2002;27-37